Larry Biegelsen
Stock Analyst at Wells Fargo
(3.75)
# 716
Out of 5,149 analysts
370
Total ratings
54.79%
Success rate
6.24%
Average return
Main Sectors:
Stocks Rated by Larry Biegelsen
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| TFX Teleflex | Maintains: Equal-Weight | $116 → $130 | $122.19 | +6.39% | 10 | Feb 27, 2026 | |
| MMSI Merit Medical Systems | Downgrades: Equal-Weight | $95 → $78 | $74.85 | +4.21% | 13 | Feb 26, 2026 | |
| ALC Alcon | Upgrades: Overweight | $88 → $97 | $83.08 | +16.75% | 10 | Feb 26, 2026 | |
| BLCO Bausch + Lomb | Maintains: Equal-Weight | $17 → $18 | $17.98 | +0.11% | 10 | Feb 19, 2026 | |
| AXGN Axogen | Initiates: Overweight | $40 | $29.83 | +34.09% | 1 | Feb 19, 2026 | |
| GKOS Glaukos | Maintains: Overweight | $122 → $135 | $117.75 | +14.65% | 18 | Feb 18, 2026 | |
| DXCM DexCom | Maintains: Overweight | $93 → $85 | $73.08 | +16.31% | 11 | Feb 13, 2026 | |
| INSP Inspire Medical Systems | Downgrades: Equal-Weight | $145 → $70 | $65.80 | +6.38% | 16 | Feb 12, 2026 | |
| ZBH Zimmer Biomet Holdings | Maintains: Equal-Weight | $93 → $98 | $97.97 | +0.03% | 11 | Feb 11, 2026 | |
| EW Edwards Lifesciences | Maintains: Overweight | $96 → $100 | $85.28 | +17.26% | 19 | Feb 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $95 → $97 | $78.13 | +24.15% | 6 | Feb 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $125 → $94 | $73.85 | +27.29% | 16 | Feb 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $38 | $23.87 | +59.20% | 1 | Jan 28, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $230 → $240 | $246.75 | -2.74% | 15 | Jan 22, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Equal-Weight | $374 | $340.16 | +9.95% | 20 | Jan 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $27 → $28 | $23.04 | +21.53% | 3 | Dec 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $72 → $82 | $83.37 | -1.64% | 20 | Dec 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $100 → $114 | $96.71 | +17.88% | 19 | Nov 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $452 → $456 | $384.59 | +18.57% | 17 | Nov 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $13 → $14 | $23.74 | -41.03% | 11 | Nov 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $9 → $10 | $7.62 | +31.23% | 16 | Nov 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $599 → $600 | $497.42 | +20.62% | 21 | Oct 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $0.68 → $0.85 | $1.06 | -19.81% | 6 | Aug 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $6 → $3 | $1.53 | +96.08% | 7 | Aug 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $33 → $24 | $19.03 | +26.12% | 17 | Aug 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Equal-Weight | $40 → $15 | $13.30 | +9.02% | 18 | Jul 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $13 → $17 | $13.83 | +22.92% | 1 | Jan 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Overweight | $40 → $49 | $10.56 | +364.02% | 2 | Dec 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $140 → $136 | $113.61 | +19.71% | 21 | Apr 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $80 → $70 | $91.70 | -23.66% | 7 | May 11, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $279 → $270 | $174.21 | +54.99% | 5 | Apr 8, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Outperform | n/a | $78.84 | - | 2 | Nov 2, 2017 |
Teleflex
Feb 27, 2026
Maintains: Equal-Weight
Price Target: $116 → $130
Current: $122.19
Upside: +6.39%
Merit Medical Systems
Feb 26, 2026
Downgrades: Equal-Weight
Price Target: $95 → $78
Current: $74.85
Upside: +4.21%
Alcon
Feb 26, 2026
Upgrades: Overweight
Price Target: $88 → $97
Current: $83.08
Upside: +16.75%
Bausch + Lomb
Feb 19, 2026
Maintains: Equal-Weight
Price Target: $17 → $18
Current: $17.98
Upside: +0.11%
Axogen
Feb 19, 2026
Initiates: Overweight
Price Target: $40
Current: $29.83
Upside: +34.09%
Glaukos
Feb 18, 2026
Maintains: Overweight
Price Target: $122 → $135
Current: $117.75
Upside: +14.65%
DexCom
Feb 13, 2026
Maintains: Overweight
Price Target: $93 → $85
Current: $73.08
Upside: +16.31%
Inspire Medical Systems
Feb 12, 2026
Downgrades: Equal-Weight
Price Target: $145 → $70
Current: $65.80
Upside: +6.38%
Zimmer Biomet Holdings
Feb 11, 2026
Maintains: Equal-Weight
Price Target: $93 → $98
Current: $97.97
Upside: +0.03%
Edwards Lifesciences
Feb 11, 2026
Maintains: Overweight
Price Target: $96 → $100
Current: $85.28
Upside: +17.26%
Feb 5, 2026
Maintains: Overweight
Price Target: $95 → $97
Current: $78.13
Upside: +24.15%
Feb 5, 2026
Maintains: Overweight
Price Target: $125 → $94
Current: $73.85
Upside: +27.29%
Jan 28, 2026
Initiates: Overweight
Price Target: $38
Current: $23.87
Upside: +59.20%
Jan 22, 2026
Maintains: Overweight
Price Target: $230 → $240
Current: $246.75
Upside: -2.74%
Jan 15, 2026
Downgrades: Equal-Weight
Price Target: $374
Current: $340.16
Upside: +9.95%
Dec 12, 2025
Maintains: Overweight
Price Target: $27 → $28
Current: $23.04
Upside: +21.53%
Dec 5, 2025
Maintains: Equal-Weight
Price Target: $72 → $82
Current: $83.37
Upside: -1.64%
Nov 19, 2025
Maintains: Overweight
Price Target: $100 → $114
Current: $96.71
Upside: +17.88%
Nov 14, 2025
Maintains: Overweight
Price Target: $452 → $456
Current: $384.59
Upside: +18.57%
Nov 7, 2025
Maintains: Equal-Weight
Price Target: $13 → $14
Current: $23.74
Upside: -41.03%
Nov 6, 2025
Maintains: Equal-Weight
Price Target: $9 → $10
Current: $7.62
Upside: +31.23%
Oct 22, 2025
Maintains: Overweight
Price Target: $599 → $600
Current: $497.42
Upside: +20.62%
Aug 15, 2025
Maintains: Equal-Weight
Price Target: $0.68 → $0.85
Current: $1.06
Upside: -19.81%
Aug 1, 2025
Maintains: Equal-Weight
Price Target: $6 → $3
Current: $1.53
Upside: +96.08%
Aug 1, 2025
Maintains: Equal-Weight
Price Target: $33 → $24
Current: $19.03
Upside: +26.12%
Jul 25, 2025
Downgrades: Equal-Weight
Price Target: $40 → $15
Current: $13.30
Upside: +9.02%
Jan 30, 2025
Maintains: Overweight
Price Target: $13 → $17
Current: $13.83
Upside: +22.92%
Dec 5, 2023
Upgrades: Overweight
Price Target: $40 → $49
Current: $10.56
Upside: +364.02%
Apr 5, 2023
Maintains: Overweight
Price Target: $140 → $136
Current: $113.61
Upside: +19.71%
May 11, 2022
Maintains: Overweight
Price Target: $80 → $70
Current: $91.70
Upside: -23.66%
Apr 8, 2020
Maintains: Overweight
Price Target: $279 → $270
Current: $174.21
Upside: +54.99%
Nov 2, 2017
Upgrades: Outperform
Price Target: n/a
Current: $78.84
Upside: -